0001596783-17-000180.txt : 20171213
0001596783-17-000180.hdr.sgml : 20171213
20171213143726
ACCESSION NUMBER: 0001596783-17-000180
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20171211
FILED AS OF DATE: 20171213
DATE AS OF CHANGE: 20171213
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Chiminski John R
CENTRAL INDEX KEY: 0001482197
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36587
FILM NUMBER: 171253618
MAIL ADDRESS:
STREET 1: C/O CATALENT, INC.
STREET 2: 14 SCHOOLHOUSE ROAD
CITY: SOMERSET
STATE: NJ
ZIP: 08873
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Catalent, Inc.
CENTRAL INDEX KEY: 0001596783
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 208737688
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 14 SCHOOLHOUSE ROAD
CITY: SOMERSET
STATE: NJ
ZIP: 08873
BUSINESS PHONE: (732) 537-6200
MAIL ADDRESS:
STREET 1: 14 SCHOOLHOUSE ROAD
CITY: SOMERSET
STATE: NJ
ZIP: 08873
FORMER COMPANY:
FORMER CONFORMED NAME: PTS Holdings Corp.
DATE OF NAME CHANGE: 20140113
4
1
wf-form4_151319383198307.xml
FORM 4
X0306
4
2017-12-11
0
0001596783
Catalent, Inc.
CTLT
0001482197
Chiminski John R
C/O CATALENT, INC.
14 SCHOOLHOUSE ROAD
SOMERSET
NJ
08873
1
1
0
0
Chair, President & CEO
Common Stock
2017-12-11
4
M
0
206685
10.71
A
536766
D
Common Stock
2017-12-11
4
F
0
125227
39.70
D
411539
D
Common Stock
2017-12-11
4
S
0
81458
39.70
D
330081
D
Common Stock
2017-12-11
4
S
0
21810
39.70
D
308271
D
Common Stock
2017-12-12
4
S
0
78190
39.51
D
230081
D
Options to purchase Common Stock
10.71
2017-12-11
4
M
0
206685
0
D
2019-10-23
Common Stock
206685.0
0
D
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2017 in order to implement a plan of financial diversification.
Includes restricted stock units.
Represents shares withheld to pay the exercise price and applicable withholding taxes associated with the exercise of stock options pursuant to the Rule 10b5-1 trading plan noted in footnote (1).
Weighted average price. These shares were sold in multiple transactions at prices ranging from $39.42 to $40.11, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (4), (5), and (6) to this Form 4.
Weighted average price. These shares were sold in multiple transactions at prices ranging from $39.61 to $39.75, inclusive.
Weighted average price. These shares were sold in multiple transactions at prices ranging from $39.21 to $39.86, inclusive.
On October 23, 2009, the reporting person was granted options to purchase common stock of the Issuer, which options began to vest and become exercisable upon the passage of time (and, in certain cases, the satisfaction of performance criteria) beginning October 23, 2010. All options have vested and been exercised or have been cancelled as of the date of this Form 4.
/s/ Jose Ibietatorremendia, attorney-in-fact
2017-12-13